Medical history, cigarette smoking and risk of acoustic neuroma: An international case-control study

International Journal of Cancer

Volumn 120, Issue 1, 2007, Pages 103-110

  Schoemaker, M J ^a   Swerdlow, A J ^a   Auvinen, A ^b,c   Christensen, H C ^d   Feychting, M ^e   Johansen, C ^d   Klaeboe L ^f   Lonn S ^e   Salminen, T ^c   Tynes, T ^f,g  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e KAROLINSKA INSTITUTE   (Sweden)

^f CANCER REGISTRY OF NORWAY   (Norway)

^g NORWEGIAN RADIATION PROTECTION AUTHORITY   (Norway)

Author keywords

Case control studies; Neuroma, acoustic; Risk factors; Smoking

Indexed keywords

SEX HORMONE;

ACOUSTIC NEURINOMA; ADULT; AGED; ALLERGIC DISEASE; ANAMNESIS; ARTICLE; CANCER INCIDENCE; CANCER INHIBITION; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; EPILEPSY; FEMALE; HEAD INJURY; HUMAN; MAJOR CLINICAL STUDY; MALE; PARITY; PRIORITY JOURNAL; RISK REDUCTION; VESTIBULOCOCHLEAR NERVE;

ADOLESCENT; ADULT; AGED; ASTHMA; CASE-CONTROL STUDIES; ECZEMA; EPILEPSY; FEMALE; HUMANS; MALE; MEDICAL HISTORY TAKING; MIDDLE AGED; NEUROMA, ACOUSTIC; RISK FACTORS; SMOKING;

EID: 33845406191     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22272     Document Type: Article

References (60)

1. Propp JM, McCarthy BJ, Davis FG, Preston-Martin S. Descriptive epidemiology of vestibular schwannomas. Neurooncol 2006;8:1-11.
2. Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery 1997;40:1-9.
3. Howitz MF, Johansen C, Tos M, Charabi S, Olsen JH. Incidence of vestibular schwannoma in Denmark, 1977-1995. Am J Otol 2000;21:690-4.
4. Tos M, Stangerup SE, Caye-Thomasen P, Tos T, Thomsen J. What is the real incidence of vestibular schwannoma? Arch Otolaryngol Head Neck Surg 2004;130:216-20.
5. Evans DG, Moran A, King A, Saeed S, Gurusinghe N, Ramsden R. Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought. Otol Neurotol 2005;26:93-7.
6. Nelson PD, Toledano MB, McConville J, Quinn MJ, Cooper N, Elliott P. Trends in acoustic neuroma and cellular phones: is there a link? Neurology 2006;66:284,285.
7. Lanser MJ, Sussman SA, Frazer K. Epidemiology, pathogenesis, and genetics of acoustic tumors. Otolarynaol Clin North Am 1992;25:499-520.
8. Ron E, Modan B, Boice JD, Jr. Alfandary E, Stovall M, Chetrit A, Katz L. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med 1988;319:1033-9.
9. Preston DL, Ron E, Yonehara S, Kobuke T, Fujii H, Kishikawa M, Tokunaga M, Tokuoka S, Mabuchi K. Tumors of the nervous system and pituitary gland associated with atomic bomb radiation exposure. J Natl Cancer Inst 2002;94:1555-63.
10. Brenner AV, Linet MS, Fine HA, Shapiro WR, Selker RG, Black PM, Inskip PD. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer 2002;99:252-9.
11. Preston-Martin S, Thomas DC, Wright WE, Henderson BE. Noise trauma in the aetiology of acoustic neuromas in men in Los Angeles County. 1978-1985. Br J Cancer 1989;59:783-6.
12. Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson MK. Use of cellular telephones and the risk for brain tumours: a case- control study. Int J Oncol 1999;15:113-16.
13. Johansen C, Boice J, Jr, McLaughlin J, Olsen J. Cellular telephones and cancer - a nationwide cohort study in Denmark. J Natl Cancer Inst 2001;93:203-7.
14. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Shapiro WR, Selker RG, Fine HA, Black PM, Loeffler JS, Linet MS. Cellular-telephone use and brain tumors. N Engl J Med 2001;344:79-86.
15. Muscat JE, Malkin MG, Shore RE, Thompson S, Neugut AI, Stellman SD, Bruce J. Handheld cellular telephones and risk of acoustic neuroma. Neurology 2002;58:1304-6.
16. Hardell L, Mild KH, Carlberg M. Further aspects on cellular and cordless telephones and brain tumours. Int J Oncol 2003;22:399-407.
17. Warren HG, Prevatt AA, Daly KA, Antonelli PJ. Cellular telephone use and risk of intratemporal facial nerve tumor. Laryngoscope 2003;113:663-7.
18. Christensen HC, Schuz J, Kosteljanetz M, Poulsen HS, Thomsen J, Johansen C. Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 2004;159:277-83.
19. Lonn S, Ahlbom A, Hall P, Feychting M. Mobile phone use and the risk of acoustic neuroma. Epidemiology 2004;15:653-9.
20. Hardell L, Carlberg M, Hansson MK. Case-control study on cellular and cordless telephones and the risk for acoustic neuroma or meningioma in patients diagnosed 2000-2003. Neuroepidemiology 2005;25:120-8.
21. Schoemaker MJ, Swerdlow AJ, Ahlbom A, Auvinen A, Blaasaas KG, Cardis E, Christensen HC, Feychting M, Hepworth SJ, Johansen C, Klaeboe L, Lonn S et al. Mobile phone use and risk of acoustic neuroma: results of the interphone case-control study in five North European countries. Br J Cancer 2005;93:842-8.
22. Cardis E, Kilkenny M. International case-control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Prot Dosimetry 1999;83:179-83.
23. Office of Population Censuses and Surveys. General practitioner morbidity statistics. London: OPCS, 1992.
24. Cox DR, Hinkley DV. Theoretical statistics. London: Chapman and Hall, 1974.
25. Stukel TA, Demidenko E, Dykes J, Karagas MR. Two-stage methods for the analysis of pooled data. Stat Med 2001;20:2115-30.
26. StataCorp. Stata statistical software: release 8.0. College Station, Texas: Stata Corporation, 2003.
27. Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den ES, Nelson LM. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol 2004;68:57-69.
28. Doll R, Peto R, Boreham J, Sutherland I. Mortality from cancer in relation to smoking: 50 years observations on British doctors. Br J Cancer 2005;92:426-9.
29. Silvera SA, Miller AB, Rohan TE. Cigarette smoking and risk of glioma: a prospective cohort study. Int J Cancer 2005;118:1848-51.
30. Terry PD, Rohan TE, Franceschi S, Weiderpass E. Cigarette smoking and the risk of endometrial cancer. Lancet Oncol 2002;3:470-80.
31. Band PR, Le ND, Fang R, Deschamps M. Carcinogenic and endocrine disrupting effects of cigarette smoke and risk of breast cancer. Lancet 2002;360:1044-9.
32. MacMahon B, Trichopoulos D, Cole P, Brown J. Cigarette smoking and urinary estrogens. N Engl J Med 1982;307:1062-5.
33. Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 1994;79:1310-16.
34. Allen NE, Appleby PN, Davey GK, Key TJ. Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. Cancer Causes Control 2002;13:353-63.
35. Muller M, den TI, Thijssen JH, Grobbee DE, van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. Eur J Endocrinol 2003;149:583-9.
36. Manjer J, Johansson R, Lenner P. Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women. Eur J Epidemiol 2005;20:331-7.
37. Hernan MA, Takkouche B, Caamano-Isorna F, Gestal-Otero JJ. A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol 2002;52:276-84.
38. Quik M. Smoking, nicotine and Parkinson's disease. Trends Neurosci 2004;27:561-8.
39. Cruickshanks KJ, Klein R, Klein BE, Wiley TL, Nondahl DM, Tweed TS. Cigarette smoking and hearing loss: the epidemiology of hearing loss study. JAMA 1998;279:1715-19.
40. Bernstein L, Pike MC, Ross RK, Judd HL, Brown JB, Henderson BE. Estrogen and sex hormone-binding globulin levels in nulliparous and parous women. J Natl Cancer Inst 1985;74:741-5.
41. Musey VC, Collins DC, Brogan DR, Santos VR, Musey PI, Martino-Saltzman D, Preedy JR. Long term effects of a first pregnancy on the hormonal environment: estrogens and androgens. J Clin Endocrinol Metab 1987;64:111-18.
42. Musey VC, Collins DC, Musey PI, Martino-Saltzman D, Preedy JR. Long-term effect of a first pregnancy on the secretion of protactin. N Engl J Med 1987;316:229-34.
43. Key TJ, Pike MC, Wang DY, Moore JW. Long term effects of a first pregnancy on serum concentrations of dehydroepiandrosterone sulfate and dehydroepiandrosterone. J Clin Endocrinol Metab 1990;70:1651-3.
44. Filipo R, Petrangeli E, Monini S, Ortolani F, Gulino A, Barbara M, Frati L. Expression of steroid receptors in acoustic neuroma. Clin Otolaryngol Allied Sci 1995;20:413-17.
45. Siglock TJ, Rosenblatt SS, Finck F, House WF, Hitselberger WE. Sex hormone receptors in acoustic neuromas. Am J Otol 1990;11:237-9.
46. Carroll RS, Zhang JP, Black PM. Hormone receptors in vestibular schwannomas. Acta Neurochir (Wien) 1997;139:188-92.
47. Gaughan RK, Harner SG. Acoustic neuroma and pregnancy. Am J Otol 1993;14:88-91.
48. Kachhara R, Devi CG, Nair S, Bhattacharya RN, Radhakrishnan VV. Acoustic neurinomas during pregnancy: report of two cases and review of literature. Acta Neurochir (Wien) 2001;143:587-91.
49. Beni-Adani L, Pomeranz S, Flores I, Shoshan Y, Ginosar Y, Ben Shachar I, Huge acoustic neurinomas presenting in the late stage of pregnancy. Treatment options and review of literature. Acta Obstet Gynecol Scand 2001;80:179-84.
50. Sharma JB, Pundir P, Sharma A. Acoustic neuroma in pregnancy: emergency cesarean section and definitive neurosurgery. Int J Gynaecol Obstet 2003;80:321-3.
51. Anderson TD, Loevner LA, Bigelow DC, Mirza N. Prevalence of unsuspected acoustic neuroma found by magnetic resonance imaging. Otolaryngol Head Neck Surg 2000;122:643-6.
52. Lin D, Hegarty JL, Fischbein NJ, Jackler RK. The prevalence of "incidental" acoustic neuroma. Arch Otolaryngol Head Neck Surg 2005; 131:241-4.
53. Forsgren L, Beghi E, Oun A, Sillanpaa M. The epidemiology of epilepsy in Europe - a systematic review. Eur J Neurol 2005;12:245-53.
54. Olsen JH, Boice JD, Jr, Jensen JP, Fraumeni JF, Jr. Cancer among epileptic patients exposed to anticonvulsant drugs. J Natl Cancer Inst 1989;81:803-8.
55. Lamminpaa A, Pukkala E, Teppo L, Neuvonen PJ. Cancer incidence among patients using antiepileptic drugs: a long-term follow-up of 28,000 patients. Eur J Clin Pharmacol 2002;58:137-41.
56. Schwartzbaum J, Jonsson F, Ahlbom A, Preston-Martin S, Malmer B, Lonn S, Soderberg K, Feychting M. Prior hospitalization for epilepsy, diabetes, and stroke and subsequent glioma and meningioma risk. Cancer Epidemiol Biomarkers Prev 2005;14:643-50.
57. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005;60:1098-111.
58. Inskip PD, Mellemkjaer L, Gridley G, Olsen JH. Incidence of intracranial tumors following hospitalisation for head injuries (Denmark). Cancer Causes Control 1998;9:109-16.
59. Inskip PD, Tarone RE, Hatch EE, Wilcosky TC, Fine HA, Black PM, Loeffler JS, Shapiro WR, Selker RG, Linet MS. Sociodemographic indicators and risk of brain tumours. Int J Epidemiol 2003;32:225-33.
60. Edwards CG, Schwartzbaum JA, Lonn S, Ahlbom A, Feychting M. Exposure to loud noise and risk of acoustic neuroma. Am J Epidemiol 2005;163:327-33.